Home » Topics » BioWorld Science, Hematologic

BioWorld Science, Hematologic
RSS

Fibrinogen antagonist from natrual source reported by Takeda

May 17, 1996

Argatroban enters phase III for HIT, HITTS

May 17, 1996

Active-site thrombin inhibitors reported by BMS

May 17, 1996

Teijin claims anticoagulant peptides

May 17, 1996

LY-329186 + aspirin effective in canine thrombosis model

May 10, 1996

Platelet antiaggregatory activity seen with Asahi's L-103

May 10, 1996

Taisho research into fibrinogen antagonists

May 10, 1996

Nippon Steel discloses anticoagulant, antithrombotic peptide

May 10, 1996

Reteplase multiple boluses claimed for thromboembolic conditions

May 3, 1996

PS-028: Fibrinogen antagonist from Taisho

May 3, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 30, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Regulatory actions for July 27, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Alfasigma,...